Brinton Eaton Company Profile

05:45 EDT 20th March 2018 | BioPortfolio

Based in Madison, NJ, Brinton Eaton is an elite, boutique advisory firm with a rich history of serving affluent individuals and their families across multiple generations. The firm helps affluent clients protect, grow, administer and ultimately transfer their client's legacy of wealth through a full range of integrated services, including lifetime cash flow projections, financial, tax, estate and retirement planning, investment management, charitable giving and business success planning. Brinton Eaton's clients tend to be corporate executives, professionals, entrepreneurs and retirees with investable assets over $2 million. For more information, visit

News Articles [12 Associated News Articles listed on BioPortfolio]

Eaton Vance Closed-End Funds Release Estimated Sources Of Distributions

Eaton Vance Enhanced Equity Income Fund (NYSE: EOI) Distribution Period:  December- 2017 Distribution Amount per Common Share:  $0.0864 Distribution Frequency: Mo...

McKesson Co. (MCK) Holdings Increased by Eaton Vance Management

Eaton Vance Management raised its holdings in shares of McKesson Co. by 4.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission.

Catalyst Pharmaceuticals Completes Enrollment in Second Phase 3 Trial of Firdapse® in Patients with Lambert-Eaton Myasthenic Syndrome

-- Top-Line Results Expected in Early December -- -- Required Abuse Liability Studies Completed -- CORAL GABLES, Fla., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasda...

Catalyst Pharmaceuticals Announces Positive Top-Line Results from Second Phase 3 Clinical Trial of Firdapse® in Patients with Lambert-Eaton Myasthenic Syndrome

-- Treatment with Firdapse Achieved Statistical Significance for Co-Primary Endpoints and Secondary Endpoint -- -- Positive Results to Support Planned NDA Submission in the First Quarter of 2018 ...

Retired Major General Issues Blistering Takedown Of Trump Parade Plan

Gen. Paul Eaton has a scathing response to President Donald Trump’s plans to hold a massive military parade in Washington.

Catalyst to re-submit rare disease drug after trial success

Catalyst Pharmaceuticals is to go back to the FDA with new data from Firdapse, its treatment for ultra-rare neuromuscular disease, Lambert- Eaton myasthenic syndrome (LEMS). The drug was rejected las...

BIIB & ALKS Team Up For MS Drug, REGN's Eylea Combo Fails Again, AEZS Rises

Today's Daily Dose brings you news about regulatory progress of Aeterna's Macrilen; BioTelemetry's collaboration with Onduo; Catalyst Pharma's Lambert-Eaton myasthenic syndrome study results and stock...

Harvest Park Becomes Hub For Cannabis Licenses In Michigan

WINDSOR TOWNSHIP, MICH. - November 27, 2017 ( Newswire) Harvest Park, a 130-acre industrial park development located in Windsor Township west of Lansing, Michigan in Eaton County is p...

Drugs and Medications [11 Associated Drugs and Medications listed on BioPortfolio]

Guanidinehydrochloridetablets [Key Pharmaceuticals, Inc.]


Erythromycin [Stat Rx USA]


Erythromycin [Rebel Distributors Corp]

Erythromycin Ophthalmic Ointment USP, 0.5% (Sterile)

Erythromycin [Bausch & Lomb Incorporated]

Erythromycin Ophthalmic Ointment USP, 0.5% (Sterile)

Erythromycin [Dispensing Solutions, Inc.]

Erythromycin Ophthalmic Ointment USP, 0.5%

PubMed Articles [9 Associated PubMed Articles listed on BioPortfolio]

Lambert-Eaton myasthenic syndrome: the 60th anniversary of Eaton and Lambert's pioneering article.

This historical review describes the contribution of Drs. Lee M. Eaton and Edward H. Lambert to the diagnosis of myasthenic syndrome on the 60th anniversary of their pioneering article (JAMA 1957) on ...

Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports.

To report our experience on 7 patients (4 males and 3 females), affected by nonparaneoplastic Lambert-Eaton myasthenic syndrome, treated with 3,4-diaminopyridine phosphate (3,4-DAPP) either alone or i...

Calcium Channel Autoimmunity: Cerebellar Ataxia and Lambert-Eaton Syndrome Coexisting.

Neuronal calcium channel antibodies are a biomarker of Lambert-Eaton syndrome (LES) and cerebellar ataxia. We have encountered several patients with LES and cerebellar ataxia coexisting and sought to ...

Lambert-Eaton myasthenic syndrome and cerebellar ataxia: Is response to immunotherapy a clue to pathogenesis?

Early active motion management of volar plate disruption of the proximal interphalangeal joint after finger hyperextension injury: extension block splinting versus buddy taping.

Background Volar plate disruption of the proximal interphalangeal joint (PIP) is a common hand injury following finger hyperextension. At our institution, patients presenting with disruptions of the p...

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

Use of 3, 4-Diaminopyridine in Lambert Eaton Myasthenic Syndrome

Compassionate use of orphan drug 3,4-Diaminopyridine (DAP) in Treatment of Lambert Eaton Myasthenic Syndrome (LEMS). The purpose of the use of this drug is to decrease the weakness associa...

Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome

OBJECTIVES: I. Evaluate the safety and effectiveness of 3,4-diaminopyridine (DAP) in the treatment of patients with Lambert-Eaton myasthenic syndrome (LEMS). II. Determine the side-effe...

Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine

The purpose of the study is to provide expanded access (compassionate use) of 3,4 diaminopyridine to patients with Lambert-Eaton myasthenic syndrome (LEMS).

Open Label Trial Of 3,4-Diaminopyridine In Lambert-Eaton Myasthenic Syndrome (LEMS)

The purpose of this study is to determine the effectiveness and adverse effects of 3,4-diaminopyridine for the treatment of the Lambert-Eaton Myasthenic Syndrome (LEMS).

Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)

This study evaluates the effect of withdrawing amifampridine phosphate treatment from patients with LEMS. One half of the patients will continue to receive amifampridine phosphate and the ...

Companies [9 Associated Companies listed on BioPortfolio]

Brinton Eaton

Based in Madison, NJ, Brinton Eaton is an elite, boutique advisory firm with a rich history of serving affluent individuals and their families across multiple generations. The firm helps affluent clie...

Eaton Corporation

Eaton is a diversified power management company providing energy-efficient solutions that help our customers effectively manage electrical, hydraulic and mechanical power. A globa...

Eaton Vance Mutual Funds

Eaton Vance is one of the oldest financial services firms in the United States, with a history dating to 1924. Reflecting the traditional values of its home in Boston, Massachusetts, Eaton Vance estab...

Eaton Vance Corp.

Eaton's Cooper Lighting business

More Information about "Brinton Eaton" on BioPortfolio

We have published hundreds of Brinton Eaton news stories on BioPortfolio along with dozens of Brinton Eaton Clinical Trials and PubMed Articles about Brinton Eaton for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Brinton Eaton Companies in our database. You can also find out about relevant Brinton Eaton Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record